Latest Integration News

Compumedics has landed a $4.2 million order for its advanced MEG system from Shandong Normal University, pushing total contracted MEG sales to around $30 million and extending revenue visibility into FY27.

Native Mineral Resources has kicked off 2026 with a record 1,475 oz gold pour at its Blackjack Gold Operations, signalling strong momentum and operational progress in Queensland.

Change Financial Limited has reported a record revenue quarter driven by its Vertexon platform growth and new client wins, prompting an upgrade to its FY26 financial guidance.

Rapid Critical Metals has completed the acquisition of the Webbs Consol Silver Project and discovered a new parallel silver lode at its Webbs Silver Project, positioning the company for significant growth in 2026.

Cyclopharm has launched a pioneering clinical study combining its Technegas imaging with AI analysis to explore a novel treatment for severe COPD, potentially expanding care options for millions.

Rumble Resources reports multiple high-grade gold and tungsten intercepts from its Western Queen project, advancing underground mine development with strong economic indicators and ongoing permitting progress.

Bayan Mining and Minerals Limited has secured exclusive rights to advanced rare earth processing technologies and made significant progress on its US exploration projects, setting the stage for maiden drilling in 2026.

Capricorn Metals reported solid December quarter gold production at Karlawinda, advanced its Mt Gibson exploration and development, and completed the Warriedar acquisition, positioning itself for growth in FY26.

Strike Resources has signed a non-binding Memorandum of Understanding with Naviera Petral to develop port infrastructure in Peru, supporting the export of its high-grade Apurimac iron ore. This strategic move aims to reduce logistics costs and pave the way for a return to production.

Adisyn Ltd has achieved a critical milestone in its pioneering low-temperature graphene deposition technology, validated by an independent expert, positioning the company for potential semiconductor industry integration.

ImpediMed reported a solid Q2 FY26 with $3.9 million in revenue and significant reimbursement gains for its lymphoedema technology, while launching new US Heart Health and Wellness initiatives.

icetana Limited reported steady growth in Q2 FY26 with a 36% increase in annual recurring revenue and expanded partnerships across APAC and the Middle East. The company’s cash flow improved, while product enhancements aim to strengthen its AI security offerings.